Published on 8/11/2004 in the Prospect News Convertibles Daily.
New Issue: ABN Amro sells $8.16 million 10% reverse exchangeables linked to Eli Lilly
New York, Aug. 11 - ABN Amro Bank NV priced $8.16 million of nine-month 10% reverse exchangeable notes linked to Eli Lilly & Co. common stock, according to a 424B3 filing with the Securities and Exchange Commission.
| Issuer: | ABN Amro Bank NV
|
| Issue: | Reverse exchangeable senior medium-term notes
|
| Underlying stock: | Eli Lilly & Co.
|
| Amount: | $8.16 million
|
| Maturity: | May 11, 2005
|
| Coupon: | 10%, payable quarterly
|
| Price: | Par
|
| Payout at maturity: | Smaller of par in cash or 16.393 shares of Eli Lilly stock
|
| Exchange ratio: | 16.393
|
| Exchange price: | $61.00 (initial level of Eli Lilly stock)
|
| Call: | Non-callable
|
| Pricing date: | Aug. 6
|
| Settlement date: | Aug. 11
|
| Lead manager: | ABN Amro Financial Services
|
| Distribution: | Off shelf
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
